Le Lézard
Classified in: Transportation, Health
Subject: AWD

Adsposure Announces Winners of Third-Annual Transit Awards


The Transit Advertising People recognized outstanding transit advertising with over 8,000 votes cast across 87 nominated campaigns.

CINCINNATI, April 24, 2024 /PRNewswire/ -- The 2023 Adsposure Transit Awards have concluded, and after a fierce two-week competition and thousands of votes, 29 campaigns were crowned first place winners!

Transit advertising campaigns were nominated in four different categories for this year's awards: Biggest Impact, Community Awareness, Creativity, and Eye-Level. Each of Adsposure's eight public transit markets participated, gathering nominees from corporations, nonprofits, and small businesses across the nation. This annual event celebrates advertising campaigns that utilize public buses, benches, and shelters as their canvas for creative and impactful messaging, and the teams behind these advertisements.

The winners of the 2023 Adsposure Transit Awards are:

Biggest Impact:
- Cincinnati: University of Cincinnati
- Des Moines: Iowa Juneteenth
- Fort Worth: Dickie's Arena
- Indianapolis: Anthem Blue Cross Blue Shield
- Kansas City: University of Missouri Kansas City
- Lexington: CareSource
- Northern Kentucky: Skyline Chili
- Youngstown: City of Youngstown

Creativity:
- Cincinnati: 4C for Children
- Des Moines: Broadlawns Medical Center
- Fort Worth: Fort Worth Zoo
- Indianapolis: IUPUI l
- Kansas City: KC Rep Theatre
- Lexington: G&J Pepsi
- Northern Kentucky: Premiere Electric

Community Awareness:
- Cincinnati: Hoxworth Blood Center
- Des Moines: Des Moines Art Center
- Fort Worth: Castleberry ISD
- Indianapolis: Fair Housing Center of Central Indiana
- Kansas City: Northland Health Care Access
- Lexington: Lexington Fayette County Health Department
- Northern Kentucky: NKY Health Department
- Youngstown: Mahoning County Public Health

Eye-Level:
- Cincinnati: Hoxworth Blood Center
- Des Moines: Des Moines Art Center
- Fort Worth: Castleberry ISD
- Indianapolis: Fair Housing Center of Central Indiana
- Kansas City: Northland Health Care Access
- Lexington: Lexington Fayette County Health Department
- Northern Kentucky: NKY Health Department
- Youngstown: Mahoning County Public Health

Additional information on the Transit Awards can be found on Adsposure's website at https://www.adsposure.com/2023-transit-awards/.

Adsposure would like to thank all our advertising and public transit agency partners for their support and participation in another successful Transit Awards!

About Adsposure:
Since 2008, Adsposure has been helping advertisers do more than simply stand out among media noise. Adsposure helps advertisers and ad agencies surpass marketing goals by increasing the frequency and reach of their Out of Home Advertising efforts and have helped transit authorities realize millions of dollars in untapped earning potential. Headquartered in Cincinnati, Adsposure has teams in Des Moines, Fort Worth, Kansas City, Lexington, Indianapolis, Northern Kentucky, and Youngstown.

Media Contact:
Morgan Schulten
[email protected]
513-729-7296

SOURCE Adsposure


These press releases may also interest you

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....

at 03:00
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...

at 02:11
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...



News published on and distributed by: